Abstract
We investigated whether polymorphisms of cytochrome P450 (CYP) and matrix metalloproteinase (MMP) are associated with the development and severity of chronic obstructive pulmonary disease (COPD). Genotypes of 184 patients with COPD and 212 controls were determined by polymerase chain reaction, followed by restriction fragment length polymorphism. The homozygous T allele of MMP-9 was significantly higher in patients with COPD than in controls (14.7% vs. 7.5%). The odds ratio was 2.4 (95% CI 1.1–5.9). No differences were observed in the frequency of polymorphic genotypes in CYP1A1, 1A2, MMP-1 and -3. During combined analysis of these candidate genes, we found strong indicators for susceptibility to COPD (combined with homozygotes *2A for CYP1A1 and T alleles of MMP-9 versus others = 3.3, 95% CI 1.2–8.6). The frequency of the homozygous *2A allele of CYP1A1 was significantly higher in very severe COPD (P < 0.01). Combinations of genetic variants including *2A homozygotes of CYP1A1 and T alleles in MMP-9 are significant indicators for susceptibility to COPD. The homozygous *2A allele of CYP1A1 is an independent risk factor for very severe COPD.
Similar content being viewed by others
References
Bascom R (1991) Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1:102–106
Cantlay AM, Lamb D, Gillooly M, Norrman J, Morrison D, Smith CA, Harrison DJ (1995) Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol 48(4):M210–M214
Cascorbi I, Brockmoller J, Roots I (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkage, and impact on lung cancer susceptibility. Cancer Res 56:4965–4969
Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T (1999) Detection of three genetic polymorphisms in the 5′ flanking region and intron 1 of human CYP1A2 in Japanese population. Jpn J Cancer Res 90(9):899–902
Crews ST, Fan CM (1999) Remembrance of things PAS, regulation of development by bHLH-PAS protein. Curr Opin Genet Dev 9:580–587
D’Armiento J, Dalal SS, Okada Y, Berg RA, Chada K (1992) Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71(6):955–961
Dunleavey L, Beyzade S, Ye S (2000a) Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 19:175–177
Dunleavey L, Beyzade S, Ye S (2000b) Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 151:587–589
Finlay GA, O’Driscoll LR, Russell KJ, D’Arcy EM, Masterson JB, FitzGerald MX, O’Connor CM (1997a) Matrix metalloproteinase expression by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156(1):240–247
Finlay GA, Russell KJ, McMahon KJ, D’arcy EM, Masterson JB, FitzGerald MX, O’Connor CM (1997b) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52(6):502–506
Fletcher C, Peto R (1977) The natural history of chronic airway obstruction. Br Med J 25:1645–1648
Fujii-Juriyama Y, Imataka H, Sogawa K, Yasumoto K, Kikuchi Y (1992) Regulation of CYP1A1 expression. FASEB J 6(2):706–710
Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH (1998) Polymorphism of the CYP1A1 and glutathione S-transferase gene in Korean lung cancer patients. Exp Mol Med 30(4):192–198
Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, D’Armiento J (2001) Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163:786–791
Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M (2005) Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 172(11):1378–1382
Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11(5):569–576
Khoury MJ, Beaty TH, Newill CA, Bryant S, Cohen BH (1986) Genetic environmental interactions in chronic airways obstruction. Int J Epidemiol 15(1):65–72
Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K (1977) Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 63(3):336–342
Kuppers F, Black LF (1974) Alpha 1-antitrypsin and its deficiency. Am Rev Respir Dis 110:176–194
Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4(5):242–246
Laurell CC, Eriksson S (1963) The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15:132–140
Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF (1998) Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58(21):4858–4863
McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA (2001) Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airway obstruction. Am J Respir Crit Care Med 164:1419–1424
Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K (2001) Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 289(1):116–119
Murphy KA, Villano CM, Dorn R, White LA (2004) Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metaoolproteinase-1 expression in keratinocytes. J Biol Chem 279(24):25284–25293
Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J. Biol. Chem 274(31):21491–21494
Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, Wilkens LR, Le Marchand L (2000) CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev 9(10):1119–1122
Nihlen U, Nyberg P, Montnemery P, Lofdahl CG (2004) Influence of family history and smoking habits on the incidence of self-reported physician’s diagnosis of COPD. Respir Med 98(3):263–270
Ohnoshi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT (1998) Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 78(9):1077–1087
Sachse C, Brockmoller J, Bauer S, Roots I (1997) Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 1A2 (CYP1A2) gene tested with caffeine. B J Clin Pharmacol 47(4):445–449
Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P, Berqstrand L, Ericsson CG, Hamsten A, Eriksson P (2005) Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 258(5):411–419
Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M (2000) Upregulation of gelatinases A and B, collagenase 1 and 2, and increased parenchymal cell death in COPD. Chest 117(3):684–694
Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population. Mol Cell Biochem 266(1–2):1–9
Villano CM, Murphy KA, Akintobi A, White LA (2006) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 210(3):212–224
Vineis P, Veglia F, Anttila S, Benhamou S, Clapper ML, Dolzan V, Ryberg D, Hirvonen A, Kremers P, Le Marchand L, Pastorelli R, Rannug A, Romkes M, Schoket B, Strange RC, Garte S, Taioli E (2004) CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene–gene interactions. Biomarkers 9(3):298–305
Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623–629
Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99(14):1788–1794
Zhou M, Huang SG, Wan HY, Li B, Deng WW, Li M (2004) Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China. Chin Med J (Engl) 117(10):1481–1484
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, SL., Yu, CJ. & Yang, PC. Genetic Polymorphisms of Cytochrome P450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease. Biochem Genet 47, 591–601 (2009). https://doi.org/10.1007/s10528-009-9252-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-009-9252-4